News & Articles

Abbott's new technology is poised to be the first point-of-care blood test for assessing concussions, providing doctors results in 15 minutes

Abbott's AlinIQ Integrated Platform analyzes currently siloed datasets to help hospitals make more informed decisions based on their unique needs

UNIVANTS of Healthcare Excellence Award winners have demonstrated how integrated care, including in the diagnostic laboratory, can transform the delivery of healthcare for value-based care

U.S. approval for MitraClip G4 brings new enhancements to the platform and offers a next-generation approach to mitral valve repair

The Afinion HbA1c Dx test provides results in just three minutes, enabling clinicians to develop informed and individualized patient care plans

Abbott introduces two new offerings within its web-based laboratory information management systems, STARLIMS

HeartMate 3 offers significant advancements for patients not eligible for a heart transplant

Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance

Long-term agreement helps ensure a safe and efficient blood supply in the Netherlands

FreeStyle Libre system can eliminate the need for routine fingersticks or any user calibration

New Alinity testing solutions to help laboratories and hospitals achieve measurably better healthcare performance

First-of-its-kind product has driven significant reimbursement in key markets, due to exceptional clinical outcome data and proven accuracy

New instrument designed to offer a highly automated and flexible solution while maintaining reliable and accurate test performance

Freestyle® Libre system eliminates routine finger pricks for glucose measurements and requires no finger pricks for calibration

Advanced tests help diagnose and detect resistance to two most widely-used, first-line drugs used in tuberculosis treatment